Search results for Hcc Screening T...

AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: E...

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death in patients with cirrhosis. Although advancements in surgical, locoregional, and systemic therapies have i...

Toward Precision HCC Surveillance: Standardizing Ultrasound Visualization and Optimizing Biomarker Integration

Abstract No. LBA15 Liquid Biopsy Detection of TP53, mGSTP1, and mRASS1Fa from Circulating Tumor DNA Improves the Non-inv...

Alpha fetoprotein (AFP) is used to screen high risk patients for hepatocellular carcinoma (HCC) but has limited sensitivity, demanding the identification of new biomarkers. This st...

Optimizing the Evaluation of Biomarkers for HCC Surveillance

Not So Fast, My Friend: Biomarkers May Play an Important Role in HCC Surveillance

Cost-Effectiveness Analysis of Resection, Ablation and Radiation Segmentectomy for Solitary Hepatocellular Carcinoma ≤ 3...

To perform a cost-effectiveness analysis comparing liver resection, percutaneous thermal ablation (TA), and radiation segmentectomy (RS) for solitary hepatocellular carcinoma (HCC)...

Abstract No. 19 Should Transarterial Chemoembolization Be Applied with Systemic Therapy for Hepatocellular Carcinoma wit...

Systemic therapy with or without radiotherapy is useful for hepatocellular carcinoma (HCC) with hepatic vein and/or inferior vena cava tumor thrombus (HVTT/IVCTT). However, the eff...

Abstract No. 20 Incidence and Factors Predictive of Recurrent Rupture in People with Rupture of Unresectable Hepatocellu...

Spontaneous rupture hemorrhage of hepatocellular carcinoma (HCC) has a low incidence and a high risk of death. Unresectable rupture hepatocellular (rHCC) carcinoma has a high early...

Rates of Successful Bridging or Downstaging and Safety of Segmental Radioembolization for Hepatocellular Carcinoma in Pa...

To evaluate the safety and rates of bridging or downstaging following segmental transarterial radioembolization (TARE) in hepatocellular carcinoma (HCC) patients with baseline hype...

Kidney cancer screening – novel concepts beyond population level screening

Screening for kidney cancer has been identified as a research priority by several independent initiatives. Previous work revealed that the relatively low prevalence of kidney cance...

Abstract No. 294 Multimodal Vision Transformer Modeling of Survival and Transplant Eligibility Following Radioembolizati...

To evaluate a multimodal 3D vision transformer model for predicting clinical outcomes following Yttrium-90 (Y-90) transarterial radioembolization (TARE) for hepatocellular carcinom...

American Cancer Society updates colorectal cancer screening guidelines, adds blood test option

The American Cancer Society released updated colorectal cancer screening guidelines May 27 that include the addition of a blood-based screening test to be taken in a doctor’s offic...

A Randomized Trial of Colonoscopy versus Fecal Immunochemical Testing versus Usual Care in the Detection of Colorectal C...

Fecal Hemoglobin-Guided Precision Post-polypectomy Surveillance within the Current Framework: A Four-Million-Participant...

Defining precision post-polypectomy surveillance intervals is essential to optimize the balance between colonoscopy resource utilization and colorectal cancer (CRC) risk reduction...

Radiologic Morphologies Predict Tumor Response and Patient Survival Following Chemoembolization for Single Large (> 5...

To evaluate the role of radiologic morphologies on oncologic outcomes following transarterial chemoembolization (TACE) in patients with inoperable, single large (> 5 to ≤ 10 cm)...

Abstract No. LBA10 DOORwaY90: Selective Internal Radiation Therapy using SIR-Spheres Y-90 Resin Microspheres as first-li...

DOORwaY90, a prospective, multicenter, open-label, single-arm study, evaluated the safety and efficacy of 90Y-resin microspheres as first-line treatment for local tumor control in...

Abstract No. 359 Predictors of Hepatic Decompensation Post-Y90 Treatment in Hepatocellular Carcinoma: New Insights into...

Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality, with transarterial radioembolization (TARE) using yttrium-90 (Y90) microspheres offering viable treatment for...

Abstract No. 358 High-Specific-Activity Resin Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: A Study of...

To evaluate efficacy, safety, voxel-based dosimetry, and particle density of high-specific-activity (HSA) resin-based (RB) Yttrium-90 radiation-segmentectomy (Y90-RS) of hepatocell...

Society updates colorectal cancer screening guideline

The American Cancer Society updated its colorectal cancer screening guideline to reflect molecular-based screening tests that received regulatory approval in the past few years.The...

Abstract No. 339 Radiomic Signal Changes Following Histotripsy Ablation of Metastatic Hepatic Lesions

To characterize radiomic changes between pre- and post-treatment CT imaging in patients undergoing liver histotripsy, with the goal of identifying imaging biomarkers of treatment r...

Blood testing is now included in screening recommendations for colon and rectal cancer

The American Cancer Society is adding some new testing options to its screening guidelines for colorectal cancers – and for the first time, that includes a blood test.

Blood test added to screening guidelines for colorectal cancers for first time

The American Cancer Society added two new screening options to their colorectal cancer screening guidelines on Wednesday.

A blood test has been added to colorectal cancer screening options. Here's what to know.

For the first time, a blood test has been added to the list of the American Cancer Society’s recommended screenings for colorectal cancer. It’s not meant to replace colonoscopies,...

Blood test added to American Cancer Society’s colorectal cancer screening options

The American Cancer Society has added a blood-based screening test to its colorectal cancer screening guidelines, providing an additional option for people who are unable or unwill...